Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
The DOI matches its Crossref record; 122 of the 127 references it cites were found in a registry or an index.
Abstract
Selective progesterone receptor modulators (SPRMs) represent a new class of progesterone receptor ligands. SPRMs exert clinically relevant tissue-selective progesterone agonist, antagonist, or mixed agonist/antagonist effects on various progesterone target tissues in vivo. Asoprisnil (J867) is the first SPRM to reach an advanced stage of clinical development for the treatment of symptomatic uterine fibroids and endometriosis. Asoprisnil belongs to the class of 11beta-benzaldoxime-substituted estratrienes that exhibit partial progesterone agonist/antagonist effects with high progesterone receptor specificity in animals and humans. Asoprisnil has no antiglucocorticoid activity in humans at therapeutic doses. It exhibits endometrial antiproliferative effects on the endometrium and breast in primates. Unlike progesterone antagonists, asoprisnil does not induce labor in relevant models of pregnancy and parturition. It induces amenorrhea primarily by targeting the endometrium. In human subjects with uterine fibroids, asoprisnil suppressed both the duration and intensity of uterine bleeding in a dose-dependent manner and reduced tumor volume in the absence of estrogen deprivation. In subjects with endometriosis, asoprisnil was effective in reducing nonmenstrual pain and dysmenorrhea. Asoprisnil may, therefore, provide a novel, tissue-selective approach to control endometriosis-related pain. SPRMs have the potential to become a novel treatment of uterine fibroids and endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, a potential good efficacy of SPRMs on endometriosis was suggested [260–262], but no SPRMs are used in clinical practice.”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [260]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M.-J., & O'Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,932
High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence
Day Baird, D., Dunson, D. B., Hill, M. C., Cousins, D., & Schectman, J. M. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.99 · Cited by 2,435
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,387
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,763
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
Research works printed but not linked: 4
- Giangrande, Recent Prog Horm Res, 54, 291
- Brenner, 2005, Asoprisnil suppresses endometrial proliferation in cynomolgus macaques., J Soc Gynecol Invest, 12, 208A
- Bilyeu, 2002, Interspecies comparison: In vitro metabolism of J867 by hepatocytes and microsomes from male and female human, and various animal species., Drug Metab Rev, 34, 46
- Morris, 2002, Interspecies comparison of the metabolism of J867 following intravenous or oral administration to male and female bile duct-cannulated rats and mice., Drug Metab Rev, 34, 73
Cited by
Items 101–200 of 315
Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis
İlhan, M., Dereli, F. T. G., & Akkol, E. K. (2018) · Current Drug Delivery · doi:10.2174/1567201816666181227112421 · Cited by 43
The role of progestins in treating the pain of endometriosis
Surrey, E. S. (2006) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2006.06.008 · Cited by 43
Huniadi, C. A., Pop, O. L., Antal, T. A., & Stamatian, F. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.03.022 · Cited by 35
“The rationale for the use of SPRMs in endometriosis lies in the selective inhibition of endometrial proliferation and the potential to suppress endometrial prostaglandin production [2,3].”
BackgroundLusher, S. J., Raaijmakers, H. C. A., Vu‐Pham, D., Kazemier, B., Bosch, R., McGuire, R., Azevedo, R., Hamersma, H., Dechering, K. J., Oubrie, A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308403 · Cited by 40
Hermon, T., Moore, A. B., Yu, L. C., Kissling, G. E., Castora, F. J., & Dixon, D. (2008) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-008-0679-5 · Cited by 35
Novel actions of progesterone: what we know today and what will be the scenario in the future?
Kaore, S. N., Langade, D., Yadav, V. K., Sharma, P., Thawani, V., & Sharma, R. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01464.x · Cited by 41
Afhüppe, W., Sommer, A., Müller, J., Schwede, W., Fuhrmann, U., & Möller, C. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.11.015 · Cited by 37
Sangkomkamhang, U. S., Lumbiganon, P., & Pattanittum, P. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008994.pub3 · Cited by 44
Options for Medical Treatment of Myomas
Rackow, B. W., & Arici, A. M. (2006) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2005.12.014 · Cited by 33
Novel agents for the medical treatment of endometriosis
Platteeuw, L., & D’Hooghe, T. (2014) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000084 · Cited by 37
Kaempferol Exhibits Progestogenic Effects in Ovariectomized Rats
Mendonca, M. F. T. E. (2013) · Journal of Steroids & Hormonal Science · doi:10.4172/2157-7536.1000136 · Cited by 35
Update on medical treatment of uterine fibroids
Faustino, F., Martinho, M. S. L., Reis, J. L., & Águas, F. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.06.047 · Cited by 36
Synthesis and Applications of Periodate for Fine Chemicals and Important Pharmaceuticals
Arndt, S., Kohlpaintner, P. J., Donsbach, K. O., & Waldvogel, S. R. (2022) · Organic Process Research & Development · doi:10.1021/acs.oprd.2c00161 · Cited by 34
Catherino, W. H., Malik, M., Driggers, P. H., Chappel, S. C., Segars, J. H., & Davis, J. B. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.05.005 · Cited by 31
New drugs in development for the treatment of endometriosis
Fedele, L., Somigliana, E., Frontino, G., Benaglia, L., & Vigano, P. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.8.1187 · Cited by 30
“Results derived from a randomized clinical trial comparing different dosages of asoprisnil, one of the most extensively investigated SPRM, indicate that a daily dose of 5 mg effectively relieves pain associated to endometriosis while only minimally influencing the bleeding pattern [61] .”
BackgroundStewart, E. A., Diamond, M. P., Williams, A. R. W., Carr, B. R., Myers, E. R., Feldman, R., Elger, W. A. G., Mattia‐Goldberg, C., Schwefel, B., & Chwalisż, K. (2019) · Human Reproduction · doi:10.1093/humrep/dez007 · Cited by 31
Self-citationMalik, M., Britten, J., Cox, J. M., Patel, A. D., & Catherino, W. H. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.09.006 · Cited by 30
Selective progesterone receptor modulators: an update
Benagiano, G., Bastianelli, C., Farris, M., & Brosens, I. A. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.914494 · Cited by 30
A new generation of progesterone receptor modulators
Winneker, R. C., Fensome, A., Zhang, P., Yudt, M. R., McComas, C. C., & Unwalla, R. J. (2008) · Steroids · doi:10.1016/j.steroids.2008.03.005 · Cited by 35
Gizard, F., Robillard, R., Gross, B. S., Barbier, O., Révillion-Carette, F., Peyrat, J., Torpier, G., Hum, D. W., & Staels, B. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00326-06 · Cited by 35
Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence
Koskas, M., Trefoux-Bourdet, A., & Luton, D. (2015) · International Journal of Women s Health · doi:10.2147/ijwh.s50016 · Cited by 29
Han, S. J., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (2007) · Endocrinology · doi:10.1210/en.2006-1561 · Cited by 33
Xu, Q., Ohara, N., Liu, J., Nakabayashi, K., DeManno, D. A., Chwalisż, K., Yoshida, S., & Maruo, T. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00210.2007 · Cited by 31
Self-citationNLRC5 and autophagy combined as possible predictors in patients with endometriosis
Zhan, L., Yao, S., Sun, S., Su, Q., Li, J., & Wei, B. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.06.028 · Cited by 27
Heikinheimo, O., Vani, S., Carpén, O., Tapper, A., Härkki, P., Rutanen, E. ‐., & Critchley, H. (2007) · Human Reproduction · doi:10.1093/humrep/dem235 · Cited by 27
Benagiano (2009) · Patient Preference and Adherence · doi:10.2147/ppa.s3692 · Cited by 29
Management of Endometriosis-associated Pain
Hansen, K. A., Chalpe, A. J., & Eyster, K. M. (2010) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3181dbda06 · Cited by 34
90 YEARS OF PROGESTERONE: Selective progesterone receptor modulators in gynaecological therapies
Critchley, H., & Chodankar, R. R. (2020) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0238 · Cited by 26
Biological characterization of non-steroidal progestins from botanicals used for women’s health
Toh, M. F., Sohn, J., Chen, S., Yao, P., Bolton, J. L., & Burdette, J. E. (2012) · Steroids · doi:10.1016/j.steroids.2012.03.013 · Cited by 33
Chronic pelvic pain and endometriosis in adolescents
Solnik, M. J. (2006) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/01.gco.0000242953.94749.2b · Cited by 25
Wilkens, J., Williams, A. R. W., Chwalisż, K., Han, C., Cameron, I. T., & Critchley, H. (2009) · Human Reproduction · doi:10.1093/humrep/den494 · Cited by 25
Selective progesterone receptor modulators 2: use in reproductive medicine
Benagiano, G., Bastianelli, C., & Farris, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.14.2473 · Cited by 24
Emerging drugs for endometriosis
Guo, S.-W. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210802548360 · Cited by 24
Ciebiera, M., Włodarczyk, M., Wrzosek, M., Słabuszewska-Jóźwiak, A., Nowicka, G., & Jakiel, G. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.11.023 · Cited by 28
Croxtall, J. D. (2012) · Drugs · doi:10.2165/11209400-000000000-00000 · Cited by 23
Lee, M. J., Yun, B. S., Seong, S. J., Kim, M., Jung, Y. W., Kim, M. K., Bae, H. S., Kim, D. H., & Hwang, J. Y. (2017) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2017.60.1.69 · Cited by 23
Current and Emerging Medical Treatments for Uterine Fibroids
Chwalisż, K., & Taylor, H. S. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1606302 · Cited by 27
The potential of selective progesterone receptor modulators for the treatment of uterine fibroids
Bestel, E., & Donnez, J. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.862495 · Cited by 23
Synthesis and biological evaluation of partially fluorinated antiprogestins and mesoprogestins
Nickisch, K. J., Elger, W. A. G., Cessac, J. W., Narkunan, K., Das, B., Garfield, R. E., Shi, S.-Q., Amelkina, O., & Meister, R. (2012) · Steroids · doi:10.1016/j.steroids.2012.09.010 · Cited by 22
Self-citationKumar, D., Moore, R. M., Mercer, B. M., Mansour, J. M., Mesiano, S. A., Schatz, F., Lockwood, C. J., & Moore, J. J. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.10.004 · Cited by 24
Feng, Q., Crochet, J. R., Dai, Q., Leppert, P. C., & Price, T. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2008 · Cited by 26
Rodriguez, M. I., Warden, M., & Darney, P. D. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.10.863 · Cited by 26
Centini, G., Cannoni, A., Ginetti, A., Colombi, I., Giorgi, M., Schettini, G., Martire, F. G., Lazzeri, L., & Zupi, E. (2024) · Diagnostics · doi:10.3390/diagnostics14182046 · Cited by 27
Selective progesterone receptor modulators 1: use during pregnancy
Benagiano, G., Bastianelli, C., & Farris, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.14.2459 · Cited by 22
Ultrastructural Features of Eutopic Endometrium in a Rat Model of Endometriosis
Elgamal, D. A., Othman, E. R., & Ahmed, S. (2015) · Journal of Microscopy and Ultrastructure · doi:10.1016/j.jmau.2015.10.002 · Cited by 22
A New Strategy for Selective Targeting of Progesterone Receptor With Passive Antagonists
Khan, J. A., Tikad, A., Fay, M., Hamzé, A., Fagart, J., Chabbert‐Buffet, N., Méduri, G., Amazit, L., Brion, J., Alami, M., et al. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1328 · Cited by 26
Emerging treatment of endometriosis
Elnashar, A. M. (2015) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2014.12.002 · Cited by 24
Dixon, D., Parrott, E. C., Segars, J. H., Olden, K., & Pinn, V. W. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.116 · Cited by 25
Doxycycline causes regression of endometriotic implants: a rat model
Akkaya, P., Önalan, G., Haberal, N., Bayraktar, N., Mülayim, B., & Zeyneloğlu, H. B. (2009) · Human Reproduction · doi:10.1093/humrep/dep106 · Cited by 19
Novel progesterone receptor modulators with gene selective and context-dependent partial agonism
Berrodin, T. J., Jelinsky, S. A., Graciani, N. R., Butera, J. A., Zhang, Z., Nagpal, S., Winneker, R. C., & Yudt, M. R. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.016 · Cited by 22
Innovations in classical hormonal targets for endometriosis
Pluchino, N., Freschi, L., Wenger, J., & Streuli, I. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1129895 · Cited by 19
Yun, B. S., Seong, S. J., Cha, D. H., Kim, J. Y., Kim, M., Shim, J. Y., & Park, J. E. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.05.022 · Cited by 18
Innovations in conservative endometriosis treatment: an updated review.
Ruhland, B., Agic, A., Krampe, J., Diedrich, K., & Hornung, D. (2011) · PubMed · Cited by 24
Synthesis and spectral properties of estrogen- and androgen-BODIPY conjugates
Osati, S., Ali, H., Guérin, B., & van Lier, J. E. (2017) · Steroids · doi:10.1016/j.steroids.2017.04.007 · Cited by 17
Kang, F., Guan, J., Jain, N. F., Allan, G. F., Linton, O., Tannenbaum, P. L., Chen, X., Xu, J. Z., Zhu, P., Gunnet, J. W., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.013 · Cited by 17
Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies
Ciebiera, M., Kociuba, J., Ali, M. K., Madueke-Laveaux, O. S., Yang, Q., Bączkowska, M., Włodarczyk, M., Żeber‐Lubecka, N., Zarychta, E., Corachán, A., et al. (2024) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2024.2390094 · Cited by 23
Traitements médicaux des tumeurs ovariennes présumées bénignes
Thomin, A., Daraï, É., & Chabbert‐Buffet, N. (2013) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2013.09.032 · Cited by 17
Selective progesterone receptor modulators: current applications and perspectives
Chabbert‐Buffet, N., Kolańska, K., Daraï, É., & Bouchard, P. (2018) · Climacteric · doi:10.1080/13697137.2017.1386650 · Cited by 16
Recent advances in structure of progestins and their binding to progesterone receptors
Cabeza, M., Heuze, Y., Sánchez, A., Garrido, M., & Bratoeff, E. (2014) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.895719 · Cited by 17
Selective progesterone receptor modulators (SPRMs) for uterine fibroids
Murji, A., Horne, A. W., Whitaker, L. H. R., Sobel, M. L., & Critchley, H. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010770 · Cited by 18
Goenka, S., & Simon, S. R. (2020) · Molecules · doi:10.3390/molecules25163581 · Cited by 15
Mikuš, M., Goldštajn, M. Š., Laganà, A. S., Vukorepa, F., & Ćorić, M. (2023) · Pharmaceuticals · doi:10.3390/ph16091315 · Cited by 20
Bouchard, P., & Chabbert‐Buffet, N. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.12.002 · Cited by 14
Irahara, M., Maejima, Y., Shinbo, N., Yamauchi, Y., & Mizunuma, H. (2019) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12304 · Cited by 14
Wang, L., Huang, H., Liu, D., Fang, S., Xian, Y., Zhou, J., Zuo, Y., Wang, F., Huang, O., & He, M. L. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.650768 · Cited by 14
Jin, C., Manikumar, G., Kepler, J. A., Cook, C. E., Allan, G. F., Kiddoe, M., Bhattacharjee, S., Linton, O., Lundeen, S. G., & Sui, Z. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.08.064 · Cited by 14
Wei, M., He, Q., Yang, Z., Wang, Z., Zhang, Q., Liu, B., Gu, Q., Su, L., Yu, Y., Zhu, Z., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-10 · Cited by 13
Yun, B. S., Seong, S. J., Jung, Y. W., Kim, M., Bae, H. S., Kim, M. K., & Shim, S. S. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.03.026 · Cited by 13
Bulun, S. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00025-1 · Cited by 19
Histomorphological changes in endometriosis in a patient treated with ulipristal: A case report
Bateman, J., Bougie, O., Singh, S. S., & Islam, S. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.10.010 · Cited by 13
LIU, H., Ma, W., LIU, Q., Fashan, W., Cao, L., Li, T., Zhang, N., & Geng, F. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2548 · Cited by 12
Selective progesterone receptor modulators and their use within gynaecology
Murdoch, M., & Roberts, M. (2014) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12072 · Cited by 12
Maruo, T., Ohara, N., Yoshida, S., Nakabayashi, K., Sasaki, H., Xu, Q., Matsuo, H., Sitruk-Ware, R. L., & Yamada, H. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.602670 · Cited by 12
Nair, H. B. B., Santhamma, B., Dileep, K. V., Binkley, P. A., Acosta, K., Zhang, K. Y. J., Schenken, R. S., & Nickisch, K. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-53467-w · Cited by 11
Hamza, M. S., Ramadan, E. S., & Salama, S. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-88346-w · Cited by 15
Progressive Fibrosis: A Progesterone- and KLF11-Mediated Sexually Dimorphic Female Response
Shenoy, C. C., Khan, Z., Zheng, Y., Jones, T. L., Khazaie, K., & Daftary, G. S. (2017) · Endocrinology · doi:10.1210/en.2017-00171 · Cited by 12
Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators
Pintiaux, A., Chabbert‐Buffet, N., & Foidart, J. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802531120 · Cited by 11
Progesterone receptor ligands for the treatment of endometriosis
Clemenza, S., Capezzuoli, T., Eren, E., GARCIA, J. M. G., Vannuccini, S., & Petraglia, F. (2022) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.22.05157-0 · Cited by 13
Ekbbal, R., Jaiswal, A. K., Aggarwal, M., Singh, M., Ali, S. A., Ali, S., & Gautam, G. (2023) · Natural Resources for Human Health · doi:10.53365/nrfhh/174668 · Cited by 28
Ligand-Induced Allosteric Effects Governing SR Signaling
Okafor, C. D., Colucci, J. K., & Ortlund, E. A. (2019) · Nuclear Receptor Research · doi:10.32527/2019/101382 · Cited by 10
An Update on Pathophysiology and Medical Management of Endometriosis
Kaur, K. K., & Allahbadia, G. (2016) · Advances in Reproductive Sciences · doi:10.4236/arsci.2016.42008 · Cited by 13
Chen, B. F., Powell, M. C., & Krstić, C. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1287687 · Cited by 10
Courtoy, G. E., Donnez, J., Marbaix, É., Barreira, M., Luyckx, M., & Dolmans, M. (2017) · Gynecologic and Obstetric Investigation · doi:10.1159/000480011 · Cited by 10
Middelkoop, M., Huirne, J. A. F., der Weide, M. C. J., Bosmans, J. E., & Hehenkamp, W. J. K. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.10.058 · Cited by 11
Jain, N. F., Allan, G. F., Linton, O., Tannenbaum, P. L., Chen, X., Xu, J. Z., Zhu, P., Gunnet, J. W., Demarest, K. T., Lundeen, S. G., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.095 · Cited by 10
Yudt, M. R., Russo, L. A., Berrodin, T. J., Jelinsky, S. A., Ellis, D. K., Cohen, J., Cooch, N. S., Haglund, E. A., Unwalla, R. J., Fensome, A., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.006 · Cited by 12
Synthesis of trisubstituted thiophenes designed as progesterone receptor modulator
Jiang, W., Fiordeliso, J. J., Chen, X., & Sui, Z. (2006) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.5570430540 · Cited by 10
Future of Endometriosis Research
Simsa, P., Mihalyi, A., Kyama, C. M., Mwenda, J. M., Fülöp, V., & D’Hooghe, T. M. (2007) · Women s Health · doi:10.2217/17455057.3.5.647 · Cited by 11
Muralidhar, B., & Reddy, S. R. (2017) · ChemistrySelect · doi:10.1002/slct.201700311 · Cited by 10
Diamond, M. P., Stewart, E. A., Williams, A. R. W., Carr, B. R., Myers, E. R., Feldman, R., Elger, W. A. G., Mattia‐Goldberg, C., Schwefel, B., & Chwalisż, K. (2019) · Human Reproduction Open · doi:10.1093/hropen/hoz027 · Cited by 11
Self-citationSynthesis and identification of novel oxa-steroids as progesterone receptor antagonists
Kang, F., Allan, G. F., Guan, J., Jain, N. F., Linton, O., Tannenbaum, P. L., Xu, J. Z., Zhu, P., Gunnet, J. W., Chen, X., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.062 · Cited by 10
Innovations in uterine fibroid therapy
McCarthy-Keith, D. M., & Armstrong, A. Y. (2011) · Therapy · doi:10.2217/thy.10.90 · Cited by 9
Sayyah-Melli, M., Mobasseri, M., Gharabaghi, P. M., Ouladsahebmadarek, E., & Rahmani, V. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.11.001 · Cited by 9
Zheng, L., Xia, K., & Mu, Y. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00315 · Cited by 9
Dynamic Regulation of Progesterone Receptor Activity in Female Reproductive Tissues
Han, S. J., DeMayo, F. J., & O’Malley, B. W. (2007) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2007_056 · Cited by 9
Cohen, J., Naoura, I., Castela, M., Nguyen, T., Oster, M., Fontaine, R. H., Chabbert‐Buffet, N., Daraï, É., & Aractingi, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.10.038 · Cited by 10
Zhang, Z., Lundeen, S. G., Slayden, O. D., Zhu, Y., Cohen, J. D., Berrodin, T., Bretz, J., Chippari, S. M., Wrobel, J. E., Zhang, P., et al. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_078 · Cited by 9
Ji, Y.-K., Lee, G., Choi, K., & Jeung, E. (2006) · Reproductive Toxicology · doi:10.1016/j.reprotox.2006.04.015 · Cited by 9
Progesterone receptor modulators in gynaecological practice
Wilkens, J., & Critchley, H. (2010) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118910791069178 · Cited by 9
New Selective Progesterone Receptor Modulators and Their Impact on the RANK/RANKL Complex Activity
Błaszczak-Świątkiewicz, K. (2020) · Molecules · doi:10.3390/molecules25061321 · Cited by 8
Metadata
- Authors
- Chwalisz, K., Perez, M. C., DeManno, D., Winkel, C., Schubert, G., & Elger, W.
- Affiliations
- TAP Pharmaceutical Products, Inc. (K.C., M.C.P., D.D.), Lake Forest, Illinois 60045;
- Georgetown University (US)
- Jenapharm GmbH & Co. (G.S.), 07745 Jena, Germany;
- EnTec GmbH (W.E.), 07745 Jena, Germany
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2005-04-27
- Volume
- 26
- Issue
- 3
- Pages
- 423-438
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1986914259
- Cited by
- 310
- References
- 127
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 5 · 2020: 9 · 2019: 16 · 2018: 18 · 2017: 23 · 2016: 11 · 2015: 21 · 2014: 19 · 2013: 21 · 2012: 21
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- selective progesterone receptor modulators, asoprisnil, uterine fibroids, leiomyoma, endometriosis, amenorrhea, dysmenorrhea, drug development
- MeSH terms
- Animals, Clinical Trials as Topic, Endometriosis, Estrenes, Female, Humans, Leiomyoma, Oximes, Oxytocics, Progesterone, Receptors, Progesterone, Uterine Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.